EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient‐reported quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator: Results from pivotal study

Samuel F Sears iD, Rebecca Harrell iD, Ian Crozier iD, Francis Murgatroyd, Lucas V A Boersma iD, Jaimie Manlucu iD, Bradley P Knight, Christophe Leclercq, Ulrika Maria Birgersdotter-Green, Christopher Wiggenhorn, Gregory Hilleren, Paul Friedman iD

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Samuel F Sears und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Department of Cardiovascular Sciences, East Carolina University, Greenville, North Carolina, USA. Hauptthemen laut MEDLINE: Defibrillators, Implantable. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The pivotal study of the extravascular implantable cardioverter‐defibrillator (EV ICD) recently demonstrated primary efficacy and safety endpoints comparable to previous ICD systems. Patient experience with this novel device has not been reported. The current study examined the standardized patient‐reported outcome (PRO) metrics of quality of life (QOL) and patient acceptance of the device.

Methods

The EV ICD Pivotal Study was a prospective, single‐arm, nonrandomized, global, premarket approval trial. Patients completed the 12‐Item Short Form Survey (SF‐12) QOL surveys at baseline and at 6 months following implant. Additionally, patients completed the Florida Patient Acceptance Survey (FPAS) QOL survey at 6 months.

Results

From baseline to 6 months, patients within the EV ICD Pivotal Study ( n = 247) reported statistically significant SF‐12 improvements in physical QOL (45.4 ± 9.4 vs. 46.8 ± 9.1 respectively, p = .020) and no changes in mental QOL (49.3 ± 10.4 vs. 50.5 ± 9.7, p = .061). No differences were noted by sex, atrial fibrillation, or the experience of ICD shock. EV ICD patients reported better total FPAS patient acceptance of their ICD than TV‐ICD or S‐ICD patients using historical norms comparisons (80.4 ± 15.7 vs. 70.2 ± 17.8, p < .0001 for S‐ICD and 73.0 ± 17.4, p = .004 for TV‐ICD).

Conclusion

The initial PROs for EV ICD patients indicated that patients had improvements in physical QOL from baseline to 6‐month follow‐up and markedly better overall acceptance of their ICD compared to a previous study with S‐ICD and TV‐ICD data. These initial results suggest that the EV ICD is evaluated positively by patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableHumansQuality of LifeProspective StudiesSurveys and QuestionnairesPatient Reported Outcome Measures

Stichwörter der Autor:innen

device acceptanceextravascular ICDpatient reported outcomesquality of life

Autor:innen und Institutionen

  • Department of Psychology, Department of Cardiovascular Sciences, East Carolina University, Greenville, North Carolina, USA.
  • Christchurch Hospital, Christchurch, New Zealand.
  • King's College Hospital, London, England.
  • Cardiology Department of St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • Amsterdam University Medical Centers Amsterdam, Amsterdam, The Netherlands.
  • London Health Sciences Centre, London, Ontario, Canada.

ORCID-Profile: Samuel F Sears, Rebecca Harrell, Ian Crozier, Lucas V A Boersma, Jaimie Manlucu, Paul Friedman

Förderung

  • Medtronic

Zitieren

APA

Sears, S. F., Harrell, R., Crozier, I., Murgatroyd, F., Boersma, L. V. A., Manlucu, J., Knight, B. P., Leclercq, C., Birgersdotter-Green, U. M., Wiggenhorn, C., Hilleren, G., & Friedman, P. (2024). Patient‐reported quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator: Results from pivotal study. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16151

Vancouver

Sears SF, Harrell R, Crozier I, Murgatroyd F, Boersma LVA, Manlucu J, et al. Patient‐reported quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator: Results from pivotal study. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16151

BibTeX
@article{Sears2024,
  author = {Sears, Samuel F and Harrell, Rebecca and Crozier, Ian and Murgatroyd, Francis and Boersma, Lucas V A and Manlucu, Jaimie and Knight, Bradley P and Leclercq, Christophe and Birgersdotter-Green, Ulrika Maria and Wiggenhorn, Christopher and Hilleren, Gregory and Friedman, Paul},
  title = {Patient‐reported quality of life and acceptance of the extravascular implantable cardioverter‐defibrillator: Results from pivotal study},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16151}
}
Kostenlos starten →